Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
1.130
+0.030 (2.73%)
At close: Apr 23, 2026, 4:00 PM EDT
1.210
+0.080 (7.08%)
After-hours: Apr 23, 2026, 6:51 PM EDT
Alzamend Neuro Market Cap
Alzamend Neuro has a market cap or net worth of $4.3 million as of April 23, 2026. Its market cap has decreased by -29.85% in one year.
Market Cap
4.30M
Enterprise Value
1.59M
1-Year Change
-29.85%
Ranking
Category
Stock Price
$1.13
Market Cap Chart
Since the IPO on June 15, 2021, Alzamend Neuro's market cap has decreased from $1.15B to $4.30M, a decrease of -99.63%. That is a compound annual growth rate of -68.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2026 | 4.19M | -39.51% |
| Dec 31, 2025 | 6.92M | 9.79% |
| Dec 31, 2024 | 6.30M | -0.56% |
| Dec 29, 2023 | 6.34M | -88.37% |
| Dec 30, 2022 | 54.47M | -67.73% |
| Dec 31, 2021 | 168.82M | -85.28% |
| Jun 15, 2021 | 1.15B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Galmed Pharmaceuticals | 4.97M |
| Pulmatrix | 4.91M |
| 60 Degrees Pharmaceuticals | 4.85M |
| Ensysce Biosciences | 4.49M |
| VivoSim Labs | 4.46M |
| Revelation Biosciences | 4.32M |
| Artelo Biosciences | 4.25M |
| AIM ImmunoTech | 3.99M |